Jazz Pharmaceuticals plc

Industry

  • Biotechnology
    • Drug Discovery Technologies
  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • Alizé Pharma II
  • Azur Pharma
  • Cavion
  • Celator Pharmaceuticals
  • Chimerix
  • EUSA Pharma
  • Gentium
  • GW Pharmaceuticals
  • Jazz Pharmaceuticals Ireland
  • Orphan Medical
See more in Biomedtracker

Latest on Jazz Pharmaceuticals plc

Scrip

ASCO: Zepzelca Tecentriq Combo A Lung Cancer Success For Jazz and Roche

 
• By Andrew McConaghie

Jazz and Roche can both expect a sales boost after a combination of their drugs has improved overall survival in extensive-stage small-cell lung cancer (SCLC). Full data from the Phase III IMforte tri

Generics Bulletin

After Jazz, Hikma Agrees $50m Settlement For ‘Most’ Xyrem ‘Pay-For-Delay’ Claims

 
• By Dean Rudge

With a jury trial previously set to begin later this month, Hikma has reached a preliminary agreement under which it would pay $50m to resolve certain class action antitrust lawsuits brought against t

Pink Sheet

PharmaMar Seeks EU Fast-Track Status For ‘Practice-Changing’ ES-SCLC Therapy

 
• By Neena Brizmohun

PharmaMar and Boehringer Ingelheim are the latest companies to ask the European Medicines Agency to fast track its review of their planned EU marketing authorization applications (MAAs) for their resp

Pink Sheet

Vertex’s Alyftrek For CF Among Six Orphans On Track For Pan-EU Approval

 
• By Eliza Slawther

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor), Vertex Pharmaceuticals’ next generation treatment for cystic fibrosis (CF) is one of six orphan products that the European Medicines Agency backed for